From: Differential proteomics for studying action mechanisms of traditional Chinese medicines
Diseases | Drugs | Potential key targets or signaling pathways | Proteomics methods | Ref. |
---|---|---|---|---|
Cancers | ||||
 Osteosarcomas | Bufalin | Heat shock 27 kDa protein | 2-DE and MALDI-TOF/TOF–MS | [6] |
 T-cell acute lymphocytic leukemia | 2-β-d-Glucopyranosyloxy-1-hydroxytrideca-5,7,9,11-tetrayne | Mitochondrial function (Parkinson disease protein 7, voltage-dependent anion-selective channel protein 2 and peroxiredoxin 3) and cell death (BH3 interacting domain death agonist and Lamin-B1 protein) | 2-DE, MALDI-MS/MS and LC–ESI–MS/MS | [7] |
 Thyroid cancer | Honokiol | Glyceraldehyde-3-phosphate dehydrogenase, tubulin alpha-1A chain, alpha-enolase, 78 kDa glucose-regulated protein, proliferating cell nuclear antigen | 2D-DIGE and MALDI-TOF–MS | [8] |
 Hepatocarcinoma | Oridonin | Heat shock 70 kDa protein 1, serine-threonine kinase receptor-associated protein, translationally-controlled tumor protein, stress-induced phosphoprotein 1, inorganic pyrophosphatase, trifunctional purine, chromobox protein homolog 1, glycyl-tRNA synthetase, poly(rC)-binding protein 1 | 2-DE and MALDI-TOF–MS/MS | [9] |
 Multiple myeloma | Oridonin | Stathmin, dihydrofolate reductase, pyruvate dehydrogenase E1β | 2-DE and MALDI-TOF–MS/MS | [10] |
 Gastric cancer | β-Elemene | Bcl-2-associated transcription factor 1, Bcl-rambo, p21-activated protein kinase-interacting protein 1, S100 calcium binding protein A10, etc. | iTRAQ and LC–MS/MS | [11] |
 Glioblastoma | β-Asarone | Heterogeneous nuclear ribonucleoprotein H1 (H) isoform CRA b, heterogeneous nuclear ribonucleo-protein A2/B1 isoform CRA a, ubiquitin carboxyl-terminal hydrolase isozyme L1, cathepsin D | 2-DE and MALDI-TOF/TOF–MS/MS | [12] |
 Lung cancer | Triptolide | Ribosome biogenesis in eukaryotes, spliceosome, mRNA surveillance pathway | iTRAQ and Nano LC–MS/MS | [13] |
β-Elemene | Peroxiredoxin-1 | 2D-DIGE and MALDI-TOF–MS | [14] | |
Cardiocerebrovascular diseases | ||||
 Cardiovascular disorders (antiplatelet) | Notoginsengnosides | Growth factor receptor-bound protein 2, thrombospondin 1, thioredoxin, Cu–Zn superoxide dismutase, Parkinson disease protein 7, peroxiredoxin 3, thioredoxin-like protein 2, ribonuclease inhibitor, myosin regulatory light chain 9, tubulin alpha 6, laminin receptor 1, potassium channel subfamily V member 2 | 2-DE and MALDI-TOF–MS/MS | [15] |
Salvianolic acids | LIM domain protein CLP-36, copine I, myosin regulatory light chain 9, coronin-1B, heat shock 70 kDa protein 2, heat shock 70 kDa protein 8, heat shock 70 kDa protein 9, peroxiredoxin 3, 3-mercaptopyruvate sulfurtransferase, fibrinogen gamma polypeptide, cytoplasmic dynein intermediate chain 2C, aminopeptidase P 1 | 2-DE and MALDI-TOF–MS/MS | [16] | |
Salvianolic acid B | Integrin α2β1 | 2-DE and MALDI-TOF–MS/MS | [17] | |
Olive oil | γ-Actin, Rho GDP-dissociation inhibitor 1, annexin A5, integrin αIIb, protein disulphide isomerase-related protein 5, fibrinogen gamma chain precursor, syntaxin-7, serine/threonine protein phosphatase | 2-DE and LC–ESI–MS | [18] | |
Rhizoma Corydalis | P2Y purinoceptor 12, Gαi signalling pathways | 2-DE and MALDI-TOF–MS/MS | [19] | |
Dehydrocorydaline, canadine | P2Y purinoceptor 1, 12 (dehydrocorydaline); G protein-coupled receptor protease-activated receptor 1 (canadine) | 2-DE and MALDI-TOF–MS/MS | [20] | |
 Cerebral IR injury | Tetrandrine | 78 kDa glucose-regulated protein, Parkinson disease protein 7 and hypoxia up-regulated protein 1 | 2-D DIGE, MALDI-TOF/TOF–MS | [21] |
Bu-Yang Huan-Wu Decoction | Albumin, fibrinogen alpha chain, transferrin, calcium/calmodulin-dependent protein kinase type II alpha chain, glycogen synthase kinase 3, microtubule-associated protein tau, metabotropic glutamate receptor 5, guanine nucleotide-binding protein G (i), GDP dissociation inhibitor and 3-hydroxybutyrate dehydrogenase | iTRAQ and LC–MS/MS | [22] | |
Tao-Hong Si-Wu Decoction | Superoxide dismutase [Cu–Zn], sulfiredoxin, glutathione S-transferase alpha-2, glutamate-cysteine ligase regulatory subunit, NAD(P)H dehydrogenase [quinone] 1, heme oxygenase 1 | 2-DE and MALDI-TOF/TOF–MS | [23] | |
 Cardiac IR injury | Salvianolic acids, notoginsengnosides | Protein disulfide-isomerase, myosin light polypeptide 3, eukaryotic translation elongation factor 2 (SAs); apolipoprotein A-I, ubiquinol-cytochrome c reductase core protein, 60 kDa heat shock protein, prohibitin (NG) | 2-DE and MALDI-TOF/TOF–MS | [24] |
Liver diseases | ||||
 Liver injury | Yin-Chen-Hao-Tang | Zinc finger protein 407, haptoglobin, macroglobulin, alpha-1-antitrypsin, transthyretin, vitamin D-binding protein, prothrombin | 2-DE and MALDI-TOF/TOF–MS | [25] |
 Liver fibrosis | Fu-Zheng Hua-Yu Recipe | Aldehyde dehydrogenase 1 family member A1, vimentin isoform CRA b, gamma-actin, vimentin, fructose-bisphosphate aldolase B, Aldo–keto reductase family 1 member D1, S-adenosylhomocysteine hydrolase isoform, Heat shock protein 90 | 2-DE and MALDI-TOF–MS | [26] |
Fu-Zheng Hua-Yu Recipe | Uridine diphosphate-glucuronosyltransferase 2A3, cytochrome P450 2B1 and cytochrome P450 3A18 in retinol metabolism pathway | iTRAQ and LC–MS/MS | [27] | |
Bupleurum marginatum Wall.ex DC | Uridine diphosphate-glucuronosyltransferase, adenylate kinase isoenzyme 1, thioredoxin 1, acyl-CoA oxidase 2, glycogenin 1, alpha serine/threonine kinase, acyl-CoA synthetase medium-chain family member 1, carbonyl reductase family member 4 | iTRAQ and LC–MS/MS | [28] | |
Wound healing | ||||
 Skin trauma | Radix Angelicae Sinensis | Triosephosphate isomerase, microtubule-associated protein RP/EB family member1, nucleoside diphosphate kinase B, glutathione S-transferase P, translationally-controlled tumor protein, peroxiredoxin, Parkinson disease protein 7, annexin A2 | 2-DE and LC–MS/MS | [29] |
Radix Lithospermi | Microtubule-associated protein RP/EB family member1, chloride intracellular channel protein 1, nucleoside diphosphate kinase A, phosphorylated signal protein P38, eukaryotic translation initiation factor 5A-1 | 2-DE and LC–MS/MS | [30] | |
Agrimonia pilosa, Nelumbo nucifera, Boswellia carteri, pollen typhae (ANBP) | β-2-Glycoprotein 1, histidinerich glycoprotein, myosin family, keratin, extracellular matrix proteins | iTRAQ, HPLC and LC–MS/MS | [31] | |
Radix Astragali, Radix Rehmanniae | Annexin A1, annexin A2, plasminogen activator inhibitor 1 | 2-DE and MALDI-TOF/TOF–MS | [32] | |
Diabetes | ||||
 T2DM | Yi-Qi-Yang-Yin-Hua-Tan-Qu-Yu Recipe | Cell division control protein 42 homolog, Ras homolog gene family member A | iTRAQ, 2D LC–MS/MS | [33] |
Xiaoke Pill | Angiotensinogen, alpha-1-antitrypsin, paraoxonase and fibulin | iTRAQ, MRM, 2D-LC, MALDI TOF/TOF–MS | [34] | |
Kaempferitrin | Insulin-like growth factor-binding protein 2 and insulin-like growth factor-binding protein 4, low-density lipoprotein receptor, C-type mannose receptor 2, adipocyte enhancer-binding protein 1, Mannan-binding lectin serine protease 1 | Dimethyl peptide labeling, LC–MS/MS | [35] | |
TCM deficiency syndrome | ||||
 Kidney-yin deficiency syndrome | Liu-Wei Di-Huang Granule | Retinol binding protein 4, transthyretin, apolipoprotein, Complement C4-B | 2-DE and MALDI-TOF–MS | [36] |
 Kidney-yang deficiency syndrome | Jin-Kui Shen-qi Pill | Wnt signaling pathway, adherens junction, neurotrophin signaling pathway, B cell receptor signaling pathway, chemokine signaling pathway, PPAR signaling pathway, Fc gamma R-mediated phagocytosis, mitogen-activated protein kinase signaling pathway | iTRAQ-LC–MS/MS and UPLC-Q-TOF-HDMS | [37] |
 Yin-deficiency-heat syndrome | Zhi-Bai Di-Huang Granule | Zinc-alpha-2-glycoprotein, C-reactive protein, complement C1q subcomponent, mannose-binding protein C, l-selectin, plasminogen and kininogen-1 | iTRAQ and 2D LC–MS/MS | [38] |
Other diseases | ||||
 Hyperlipidemia | Yin-Chen Wu-Ling Powder | Apolipoprotein E, serum albumin, transthyretin and vitamin D-binding protein; T-kininogen, complement C3, C4, C4b-binding protein alpha chain, Igλ-2 chainC, mannose-binding protein C, hemopexin and fibrinogen-like protein 1 | 2-DE and MALDI-TOF–MS | [39] |
 Obesity | Taeumjowi-tang | Fatty acid synthetase, adenosine monophosphate-activated protein kinase/acetyl CoA carboxylase pathway | 2-DE and MALDI-TOF–MS | [40] |
 Depression | Shen-Zhi-Ling tablet | Von Willebrand factor, protein Z-dependent protease inhibitor, alpha-2-macroglobulin, apolipoprotein C-III | label-free and LC–MS/MS | [41] |
 Chronic obstructive pulmonary disease | Bu-Fei Yi-Shen formula | Oxidative stress and focal adhesion pathway | iTRAQ and Nano LC–MS/MS | [42] |
 Fever | Bai-Hu-Tang | F-actin, coronin, nicotinamide adenine dinucleotide phosphate oxidase, major histocompatibility complex class I | iTRAQ and LC–MS | [43] |
 Aging | Red ginseng | Ubiquitin carboxyl-terminal hydrolase isozyme L1, heat shock 70 kDa protein, fructose-bisphosphate aldolase | 2-DE and MALDI-TOF–MS | [44] |